Atlas Trials

Metastatic Adenocarcinoma of the Pancreas

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Adenocarcinoma of the Pancreas

RecordFirmDate
A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1 (NCT06867497)Boryung Pharmaceutical Co., Ltd2025-02-24
Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas (NCT06225999)Institut de Recherches Internationales Servier2024-04-25
Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas (NCT05557851)Minneamrita Therapeutics LLC2022-11-01
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment (NCT04083235)Ipsen2020-02-11
Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas (NCT02739633)Samyang Biopharmaceuticals Corporation2016-04-01
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy (NCT02184195)AstraZeneca2014-12-16
Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC) (NCT01654861)Eastern Regional Medical Center2012-06-01
Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients (NCT00873353)Grupo Gallego de Investigaciones Oncologicas2008-03-01

Track Metastatic Adenocarcinoma of the Pancreas automatically

Every clearance here is in the API, with alerts when new ones post.